BclAF1 restriction factor is neutralized by proteasomal degradation and microRNA repression during human cytomegalovirus infection.

TitleBclAF1 restriction factor is neutralized by proteasomal degradation and microRNA repression during human cytomegalovirus infection.
Publication TypeJournal Articles
Year of Publication2012
AuthorsLee SHee, Kalejta RF, Kerry J, Semmes OJohn, O'Connor CM, Khan Z, Garcia BA, Shenk T, Murphy E
JournalProc Natl Acad Sci U S A
Volume109
Issue24
Pagination9575-80
Date Published2012 Jun 12
ISSN1091-6490
KeywordsCytomegalovirus, Cytomegalovirus Infections, Genes, Immediate-Early, HUMANS, Hydrolysis, MicroRNAs, Proteasome Endopeptidase Complex, Repressor Proteins, Tumor Suppressor Proteins
Abstract

Cell proteins can restrict the replication of viruses. Here, we identify the cellular BclAF1 protein as a human cytomegalovirus restriction factor and describe two independent mechanisms the virus uses to decrease its steady-state levels. Immediately following infection, the viral pp71 and UL35 proteins, which are delivered to cells within virions, direct the proteasomal degradation of BclAF1. Although BclAF1 reaccumulates through the middle stages of infection, it is subsequently down-regulated at late times by miR-UL112-1, a virus-encoded microRNA. In the absence of BclAF1 neutralization, viral gene expression and replication are inhibited. These data identify two temporally and mechanistically distinct functions used by human cytomegalovirus to down-regulate a cellular antiviral protein.

DOI10.1073/pnas.1207496109
Alternate JournalProc. Natl. Acad. Sci. U.S.A.
PubMed ID22645331
PubMed Central IDPMC3386064
Grant ListAI074800 / AI / NIAID NIH HHS / United States
AI074984 / AI / NIAID NIH HHS / United States
CA082396 / CA / NCI NIH HHS / United States
GM071508 / GM / NIGMS NIH HHS / United States
R01 CA076595 / CA / NCI NIH HHS / United States